Figure 3. Forest plots of the results of progression-free survival analysis. Univariate analysis of progression-free survival found that responding to treatment hazard ratio=4.310) and low neutrophil-to-lymphocyte ratio (NLR) (hazard ratio=3.940, p=0.016) were factors associated with a favorable prognosis.